RECRUITING

Effect of Melatonin on Sleep Patterns of Resident Trainees During Night Float Shift

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Anesthesiology residency requires extended and overnight shifts, which may negatively impact the quantity and quality of sleep. Previous studies have investigated the effect of night float shift work on anesthesiology resident sleep and performance and demonstrated that total sleep quantity and time spent in deep and rapid eye movement (REM) sleep were significantly reduced during night float and did not return to baseline after 3 nights of recovery. Melatonin is a hormone produced by the pineal gland, which regulates the circadian rhythm that governs sleep. Exogenous melatonin may be used as a sleep aid and is available over the counter in the United States. Melatonin is effective in realigning the circadian rhythm disorder caused by night shift work and increasing sleep duration; however, melatonin's effect on improving sleep in resident trainees has not been investigated. The investigators propose a prospective double-blinded randomized control trial to investigate the effect of melatonin on sleep quantity and quality in resident physicians assigned to a night float system.

Official Title

Effect of Melatonin on Sleep Patterns of Resident Trainees During Night Float Shift

Quick Facts

Study Start:2022-05-30
Study Completion:2024-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05701969

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Post-Graduate Year 1-5
  2. * Current enrollment in anesthesiology, general surgery, obstetrics and gynecology, general medicine, or pediatrics residency at the Unversity of Virginia
  1. * Current use of sleep aids
  2. * Diagnosed sleep disorder
  3. * History of a pacemaker or other medical device.
  4. * pregnant or breast-feeding females
  5. * Bleeding disorders
  6. * Depression
  7. * High blood pressure
  8. * Seizure disorders
  9. * History of transplant on immunosuppression therapy.

Contacts and Locations

Study Contact

Keita Ikeda, PH.D.
CONTACT
9195931174
ki2d@uvahealth.org
Emily Chuang, MA
CONTACT
7575348912
QGZ2TK@uvahealth.org

Principal Investigator

Lauren Dunn, MD PHD
PRINCIPAL_INVESTIGATOR
University of Virginia

Study Locations (Sites)

University of Virginia
Charlottesville, Virginia, 22908-0710
United States

Collaborators and Investigators

Sponsor: University of Virginia

  • Lauren Dunn, MD PHD, PRINCIPAL_INVESTIGATOR, University of Virginia

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-30
Study Completion Date2024-06-30

Study Record Updates

Study Start Date2022-05-30
Study Completion Date2024-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Sleep Disorders, Circadian Rhythm